Patient-derived surgical specimens were subjected to molecular analysis, which revealed the tissue to be GBM with the tumor cells highly expressing GFAP, Ki67, and IDH1 R132H (Figure 5(a)). The gene discussed is GFAP; the disease is neoplasm.